NGM BIOPHARMACEUTICALS INC (NGM) Stock Analyst Earnings Estimates
NASDAQ:NGM - Nasdaq - US62921N1054 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 77.9M -10.87% | 55.3M -29.01% | 4.417M -92.01% | -100.00% | 36.036M | 17.242M -52.15% | 67.744M 292.90% | 236.12M 248.55% | 357.81M 51.54% | ||
| EBITDA YoY % growth | -114.61M -17.86% | -162.16M -41.49% | -149.242M 7.97% | -162.008M -8.55% | -168.2M -3.82% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -120.7M -16.28% | -166.2M -37.70% | -151.463M 8.87% | -128.369M 15.25% | -127.729M 0.50% | -104.545M 18.15% | -88.592M 15.26% | -43.749M 50.62% | 96.61M 320.83% | 191.75M 98.48% | |
| Operating Margin | -154.94% | -300.54% | -3,429.09% | N/A | N/A | -290.11% | -513.81% | -64.58% | 40.92% | 53.59% | |
| EPS YoY % growth | -1.56 -4.70% | -2.05 -31.41% | -1.72 16.10% | -1.21 29.44% | -0.95 21.40% | -1.03 -8.01% | -1.03 | -1.03 | -0.43 57.84% | 0.15 134.88% |
All data in USD
| Q1 / 24 | Q2 / 24 | Q3 / 24 | Q4 / 24 | |
|---|---|---|---|---|
| EPS Q2Q % growth | -0.46 19.90% | -0.29 36.33% | -0.23 33.63% | -0.19 41.85% |
| Revenue Q2Q % growth | -100.00% | -100.00% | -100.00% | -100.00% |
| EBITDA Q2Q % growth | -31.008M 37.46% | -32.767M 16.86% | -34.469M -17.52% | N/A |
| EBIT Q2Q % growth | -49.148M 2.08% | -44.246M -9.03% | -34.684M -11.78% | -29.421M 0.81% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2023 Q2Q % growth | -0.33 26.67% | -0.40 | 0.07 | 16.90% |
| Q3 2023 Q2Q % growth | -0.35 40.68% | -0.43 | 0.08 | 18.33% |
| Q2 2023 Q2Q % growth | -0.46 22.03% | -0.50 | 0.04 | 8.51% |
| Q1 2023 Q2Q % growth | -0.58 -38.10% | -0.52 | -0.06 | -11.04% |
| Q4 2022 Q2Q % growth | -0.45 -28.57% | -0.52 | 0.07 | 13.49% |
| Q3 2022 Q2Q % growth | -0.59 -59.46% | -0.60 | 0.01 | 1.27% |
| Q2 2022 Q2Q % growth | -0.59 -22.92% | -0.56 | -0.03 | -6.21% |
| Q1 2022 Q2Q % growth | -0.42 -16.67% | -0.46 | 0.04 | 9.20% |
| Q4 2021 Q2Q % growth | -0.35 12.50% | -0.36 | 0.01 | 3.74% |
| Q3 2021 Q2Q % growth | -0.37 13.95% | -0.35 | -0.02 | -4.67% |
| Q2 2021 Q2Q % growth | -0.48 -26.32% | -0.38 | -0.10 | -27.87% |
| Q1 2021 Q2Q % growth | -0.36 -28.57% | -0.42 | 0.06 | 14.88% |
| Q4 2020 Q2Q % growth | -0.40 -66.67% | -0.48 | 0.08 | 15.93% |
| Q3 2020 Q2Q % growth | -0.43 -152.94% | -0.38 | -0.05 | -12.43% |
| Q2 2020 Q2Q % growth | -0.38 -192.31% | -0.32 | -0.06 | -20.20% |
| Q1 2020 Q2Q % growth | -0.28 76.86% | -0.27 | -0.01 | -3.64% |
| Q4 2019 Q2Q % growth | -0.24 | -0.27 | 0.03 | 11.14% |
| Q3 2019 Q2Q % growth | -0.17 | -0.28 | 0.11 | 39.80% |
| Q2 2019 Q2Q % growth | -0.13 | -0.25 | 0.12 | 46.96% |
| Q1 2019 Q2Q % growth | -1.21 | -0.28 | -0.93 | -332.50% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2023 Q2Q % growth | 165K -99.09% | 563.782K | -398.782K | -70.73% |
| Q3 2023 Q2Q % growth | 580K -92.67% | 2.48M | -1.9M | -76.61% |
| Q2 2023 Q2Q % growth | 1.42M -82.87% | 3.337M | -1.917M | -57.45% |
| Q1 2023 Q2Q % growth | 2.25M -89.26% | 6.198M | -3.948M | -63.70% |
| Q4 2022 Q2Q % growth | 18.18M -13.26% | 6.831M | 11.349M | 166.14% |
| Q3 2022 Q2Q % growth | 7.91M -57.43% | 7.135M | 775K | 10.86% |
| Q2 2022 Q2Q % growth | 8.29M -50.57% | 13.533M | -5.243M | -38.74% |
| Q1 2022 Q2Q % growth | 20.95M -2.92% | 18.868M | 2.082M | 11.03% |
| Q4 2021 Q2Q % growth | 20.96M 6.02% | 20.398M | 562K | 2.76% |
| Q3 2021 Q2Q % growth | 18.58M -20.87% | 22.879M | -4.299M | -18.79% |
| Q2 2021 Q2Q % growth | 16.77M -15.13% | 22.708M | -5.938M | -26.15% |
| Q1 2021 Q2Q % growth | 21.58M -11.41% | 22.717M | -1.137M | -5.01% |
| Q4 2020 Q2Q % growth | 19.77M -36.39% | 22.186M | -2.416M | -10.89% |
| Q3 2020 Q2Q % growth | 23.48M 8.85% | 20.019M | 3.461M | 17.29% |
| Q2 2020 Q2Q % growth | 19.76M -22.02% | 21.996M | -2.236M | -10.17% |
| Q1 2020 Q2Q % growth | 24.36M -4.66% | 23.18M | 1.18M | 5.09% |
| Q4 2019 Q2Q % growth | 31.08M | 16.21M | 14.87M | 91.73% |
| Q3 2019 Q2Q % growth | 21.57M | 18.047M | 3.523M | 19.52% |
| Q2 2019 Q2Q % growth | 25.34M | 20.932M | 4.408M | 21.06% |
| Q1 2019 Q2Q % growth | 25.55M | 21.803M | 3.747M | 17.19% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -27.96% | -27.96% | 0% | 0% |
| Revenue | -100% | -100% | -100% | -100% |